Literature DB >> 22840589

Rapid detection of Haemophilus influenzae and Haemophilus parainfluenzae in nasopharyngeal swabs by multiplex PCR.

Guo Zhong Tian1, Li Juan Zhang, Xiao Lei Wang, Li Zhang, Shu Feng Li, Chang Mei Gu, Jian Sun, Bu Yun Cui.   

Abstract

OBJECTIVE: To establish multiplex PCR-based assays for detecting H.influenzae and H.parainfluenzae. And the PCR-based assays were applied to detect the carriage rates of H.influenzae and H.parainfluenzae in nasopharyngeal swab specimens which were collected from healthy children.
METHODS: Multiplex primers for species-specific PCR were designed by using DNAstar soft based on the sequences of 16S rRNA genes from genus Haemophilus to detect H.influenzae and H.parainfluenzae.
RESULTS: The sensitivity of the 16S rRNA PCR assay for detecting H.influenzae and H.parainfluenzae was 97.53% and 100% respectively, and the specificity was 95.89% and 96.63% respectively. Youden's Index on the ability to detect H.influenzae and H.parainfluenzae was 0.9342 and 0.9663 respectively. 666 nasopharyngeal swab specimens were collected from healthy children. The detection rates of H.influenzae and H.parainfluenzae were 14.11% and 16.07% respectively by using isolation and culture methods. The detection rates of H.influenzae and H.parainfluenzae were 43.54% and 57.96% respectively by 16S rRNA PCR assays. The carriage rates of serotypes a, b, c, d, e, f and non-typeable isolates were 0% (0/666), 0.15% (1/666), 1.20% (8/666), 0.15% (1/666), 1.20% (8/666), 1.80% (12/666), 95.50% (636/666) respectively.
CONCLUSION: The multiplex PCR assays were very rapid, reliable and feasible methods for detection of H.influenzae and H.parainfluenzae in pharyngeal swab specimens which were compared to conventional isolation and culture methods. 95.5% of H.influenzae strains in healthy children were nontypeable. The encapsulated or typable strains were mainly three serotypes which was c, e, and f serotype.
Copyright © 2012 The Editorial Board of Biomedical and Environmental Sciences. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22840589     DOI: 10.3967/0895-3988.2012.03.016

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  6 in total

1.  Emergence of extensively drug-resistant Haemophilus parainfluenzae in Switzerland.

Authors:  Regula Tinguely; Salome N Seiffert; Hansjakob Furrer; Vincent Perreten; Sara Droz; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

2.  DNA aptamers for the detection of Haemophilus influenzae type b by cell SELEX.

Authors:  F S Bitaraf; I Rasooli; S L Mousavi Gargari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-14       Impact factor: 3.267

Review 3.  Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae.

Authors:  Lydia J Finney; Andrew Ritchie; Elizabeth Pollard; Sebastian L Johnston; Patrick Mallia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-10-13

4.  Simultaneous Detection of Nine Key Bacterial Respiratory Pathogens Using Luminex xTAG® Technology.

Authors:  Luxi Jiang; Hongyu Ren; Haijian Zhou; Tian Qin; Yu Chen
Journal:  Int J Environ Res Public Health       Date:  2017-02-23       Impact factor: 3.390

5.  Real-time multiple cross displacement amplification assay for rapid and sensitive detection of Haemophilus influenzae.

Authors:  Chunrong Sun; Nan Jia; Xiaolan Huang; Fei Xiao; Juan Zhou; Yu Zhang; Jin Fu; Zheng Xu; Dong Qu; Xiaodai Cui; Yi Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-09-27       Impact factor: 6.073

6.  Rapid discrimination of Haemophilus influenzae, H. parainfluenzae, and H. haemolyticus by fluorescence in situ hybridization (FISH) and two matrix-assisted laser-desorption-ionization time-of-flight mass spectrometry (MALDI-TOF-MS) platforms.

Authors:  Hagen Frickmann; Martin Christner; Martina Donat; Anja Berger; Andreas Essig; Andreas Podbielski; Ralf Matthias Hagen; Sven Poppert
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.